// App-Quantinova.ai

POS0104 (2021) : ESSDAI AND ITS ASSOCIATION WITH PATIENT OUTCOMES IN SJÖGREN’S SYNDROME: A REAL-WORLD SURVEY IN THE US

Researchers

Presenter

  • B. Ndife

Principal Investigators

  • B. Hoskin

  • N. Booth

Medical Centers

  • Novartis Pharmaceuticals Corporation, US HEOR, East Hanover, United States of America

  • Adelphi Real World, Adelphi Real World, Macclesfield, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Sjogren's syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A